false 0000727346 0000727346 2025-01-17 2025-01-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 17, 2025

 

SELECTIS HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)

 

Utah   0-15415   87-0340206

(State or other jurisdiction

of incorporation)

  

Commission

File Number

  

(I.R.S. Employer

Identification number)

 

8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (720) 680-0808

 

 

(Former name or former address, if changed since last report)

 

☐ Written communications pursuant to Rule 425 under the Securities Act
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

ITEM 5.02DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER

 

On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date. Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified. A copy of the Separation Agreement and Release is filed herewith as Exhibit 10.1.

 

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS

 

Exhibit

 

10.1   Separation Agreement and Release
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Selectis Health, Inc.
  (Registrant)
   
Dated: January 23, 2025 /s/ Adam Desmond
  Adam Desmond, CEO

 

 

 

Exhibit 10.1

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 

 

v3.24.4
Cover
Jan. 17, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 17, 2025
Entity File Number 0-15415
Entity Registrant Name SELECTIS HEALTH, INC
Entity Central Index Key 0000727346
Entity Tax Identification Number 87-0340206
Entity Incorporation, State or Country Code UT
Entity Address, Address Line One 8480 E. Orchard Road
Entity Address, Address Line Two Ste. 4900
Entity Address, City or Town Greenwood Village
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80111
City Area Code (720)
Local Phone Number 680-0808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Selectis Health (PK) Charts.
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Selectis Health (PK) Charts.